Cloned DNA representing the sequence coding for the non-structural protein 3A from cucumber mosaic virus (CMV) was inserted in an expression vector containing a truncated portion of the Protein A gene from Staphylococcus aureus. Expressed fusion protein was purified from Escherichia coli cell extracts by affinity chromatography on rabbit gamma globulin-conjugated Sepharose and used as an immunogen for the production of monoclonal antibodies (MAbs). Five MAbs that reacted with pXCM3AI3 fusion protein in solid phase ELISA were able to immunoprecipitate specifically protein 3A from mixtures of in vitro translation products of CMV RNA. None of these antibodies reacted with the analogous protein in translation products of brome mosaic virus RNA, but all of them reacted with the 3A protein from tomato aspermy virus. Immunogold labelling of ultrathin sections of CMV-infected tobacco tissue with MAb 3H12 demonstrated that the 3A protein accumulated within the nucleoli of these cells. This location differs from that of the analogous 3A protein of alfalfa mosaic virus which is associated with the middle lamella of the cell walls of infected tobacco cells.
INTRODUCTION
Cucumber mosaic virus (CMV) particles contain four single-stranded (+) RNA species designated RNA 1 to 4 in order of decreasing size (Mr 1.35 x 106, 1.16 x 106, 0.85 x 106 and 0-35 x 106) (Peden & Symons, t973) . RNAs 1 and 2 are monocistronic and code for translation products of Mr 95 000 and 110 000 respectively, while RNA 3 is dicistronic and codes for both the 3A protein (Mr 35000) and the virus coat protein (Mr 24500) (Gordon et al., 1982; Schwinghamer & Symons, 1977) . Only RNAs 1, 2 and 3 are required for infection, while RNA 4 is a subgenomic message containing the coat protein cistron.
The entire genome of CMV has recently been sequenced (Rezaian et al., 1984 (Rezaian et al., , 1985 Gould & Symons, 1982) and quite substantial amino acid sequence homology has been found between the translation products of CMV RNAs 1 and 2 and the translation products of the corresponding RNAs from brome mosaic virus (BMV) and alfalfa mosaic virus (A1MV). This high degree of sequence homology, together with the fact that RNAs 1 and 2 of BMV and A1MV have been shown to replicate in protoplasts in the absence of RNA 3 (Kiberstis et al., 1981 ; Nassuth et al., 1981) , suggests that these proteins are involved in RNA replication.
Although the amino acid sequences of the coat proteins of A1MV, BMV and CMV show little or no homology (Ahlquist et al., 1985; Murthy, 1983 ) the 3A proteins of these viruses exhibit significant sequence homology. The most extensive homology is found between the BMV and CMV proteins (approx. 34%) and the least is between the A1MV and CMV proteins (approx. 14%) (Murthy, 1983 ; Savithri & Murthy, 1983) . There is as yet no direct biochemical evidence to suggest a specific function for the 3A proteins of these tripartite viruses. In contrast, there is a 0000-8307 growing body of evidence which indicates that the non-structural p30 protein of tobacco mosaic virus (TMV) is involved in the cell-to-cell movement of viral RNA (Leonard & Zaitlin, 1982; Ohno et al., 1983; Zimmern & Hunter, 1983) . The p30 protein is, however, not homologous to the 3A proteins of A1MV, BMV or CMV, and its sequence varies quite significantly between different strains of TMV (Meshi et al., 1982; Zimmern, 1983) . Nevertheless, recent work involving the localization of the 3A protein of A1MV in the cell wall fraction of infected tobacco plants has led some workers to speculate that this protein may be directly involved in the cell-tocell spread of the virus (Godefroy-Colburn et al., 1986; Stussi-Garaud et al., 1987) .
In this paper we report the preparation of a full length cDNA clone of the 3A protein of CMV, the construction of an expression vector containing the 3A gene as an in-frame fusion with that encoding Protein A, the production and characterization of specific monoclonal antibodies (MAbs) to this cloned protein and the ultrastructural location of the 3A protein in virus-infected tissue.
METHODS

Materials.
A culture of the Q strain of CMV was obtained from R. Symons, University of Adelaide, Australia and was purified from infected cucumber as described by Francki et al. (1979) . Viral RNA was purified from alkaline SDS-treated virus particles (Peden & Symons, 1973) . Restriction endonucleases and the pUC13 and pRIT2T vectors were obtained from Pharmacia. All other chemicals were of ACS grade or better.
Preparation of cDNA and plasmid construction. In general, recombinant DNA manipulations were carried out essentially as described by Maniatis et al., 1982 . A synthetic 24-mer oligonucleotide with the sequence 5'-TTGAATTGAACCTTAAAACTGTGA-3', complementary to the T-terminal region of the CMV 3A gene, was synthesized using solid phase phosphoramidite chemistry and used as a primer for first strand cDNA synthesis utilizing cloned Moloney murine leukaemia virus reverse transcriptase (D'Alessio et al., 1987) and purified CMV RNA as a template. Second strand synthesis was accomplished with Escherichia cob DNA polymerase I followed by treatment with E. coli RNase H. This double-stranded cDNA was homopolymer-tailed with dCTP and inserted into PstI-digested, dGTP-tailed pUC 13. The resulting construct was used to transform competent DH5ct cells to ampicillin resistance. One recombinant clone, designated pCM3A 11, contained a 1.1 kb insert which represented the entire reading frame of the CMV 3A protein gene. The 1.1 kb fragment obtained by PstI digestion of pCM3A11 was gel-purified and further digested with AvalI which cut the fragment at a residue equivalent to position 108 in the CMV RNA 3 sequence. After treatment with the Klenow fragment of DNA polymerase I, the restriction fragment, which contained a blunt 5' terminus and a PstI-compatible 3' terminus, was ligated with pRIT2T that had been digested with Sinai and PstI. This construct was used to transform E. coli N4830-1 cells, which contain the phage 2 c1857 temperature-sensitive repressor, to ampicillin resistance. Plasmids from such transformed cultures were digested with EcoRI and PstI to confirm the size of the cloned insert and the expression of fusion protein was determined by SDS-PAGE of cell lysates.
Preparation and purification of pXCM3A13 fusion protein. Cultures containing the pXCM3A13 plasmid were grown at 30°C in Luria broth, supplemented with ampicillin (20 ~tg/ml) and 0.1 ~ casamino acids, to an OD600 of 0-8, then fusion protein synthesis was induced by a temperature shift to 42 °C by mixing the cultures with an equal volume of medium heated to 54 °C. Cultures were maintained at 42 °C for 90 rain, after which cells were harvested by centrifugation at 4000 g for 20 min. The cell pellet was resuspended in 50 volumes of TST (10 mM-Tris-HC1 pH 7-4, 0.15 M-NaC1, 0.05~ Tween 20) containing 0-1 mM-phenylmethylsulphonyl fluoride and subjected to three cycles of sonication to disrupt cells. The sonicated cell extract was clarified by centrifugation at 25 000 g for 30 min and chromatographed over a rabbit gamma globulin-Sepharose 2B affinity column. Specifically bound fusion protein was eluted with 0.1 M-acetic acid, lyophilized and stored at -20 °C in the presence of 50~ glycerol.
Immunization and cell fusion. Female BALB/c mice were successively immunized at 10 day intervals by intraperitoneal injection with 100 ~tg quantities of purified pXCM3A 13 fusion protein over a period of 6 weeks. Four days after the final immunization, spleen cells were harvested and fused with the FXNY strain of mouse myeloma cells in the presence of 50~ polyethylene glycol 4000 (BDH). Hybridoma cells were cultured in Dulbecco's modified minimum essential medium containing 100 p.M-hypoxanthine, 0"4 p.M-aminopterin, 16 ~tM-thymidine, 20~ foetal calf serum (FCS), and 5 x 105 syngeneic feeder thymocytes per ml. Specific antibodysecreting clones were identified by ELISA using purified pXCM3A13 fusion protein or Protein A (Pharmacia) as the immobilized antigen. These cultures were recloned by limiting dilution and stored frozen in liquid nitrogen in medium containing 20 ~ FCS and 10 ~ DMSO. For the production of large quantities of specific MAb, hybridoma cells were propagated as ascites tumours in BALB/c mice previously injected with 0.5 ml of pristane (Sigma).
ELISA. Culture fluids were screened against both immobilized pXCM3A13 fusion protein and Protein A. Those which reacted well with the pXMC3A13 fusion protein but not with Protein A were initially judged as positive.
Linbro microtitre plate wells (Flow Laboratories) were coated overnight at 4 °C with 100/.tl of rabbit gamma globulin at 50 Ixg/ml in 50 mM-sodium carbonate buffer pH 9.6. The wells were then rinsed and incubated for 8 to 16 h (4 °C) with either affinity-purified pXCM3A13 fusion protein or Protein A at 1 ~tg/ml in blocking buffer [20 mM-Tris-HCl pH 7-4, 0.1 M-NaCI, 1 ~ bovine serum albumin (BSA), 0.05~ Tween 20, 0.1 ~ NAN3]. Antigencoated wells were rinsed with water and incubated with 100 ~tl of diluted hybridoma culture fluid for 60 to 90 min, rinsed, and incubated with 100 ~tl of goat anti-mouse immunoglobulin-conjugated alkaline phosphatase (Bio/Can), at 200 ng/ml in blocking buffer, for 90 min. Approximately 60 to 90 min after the addition of p-nitrophenyl phosphate substrate (0.5 mg/ml in 10~ diethanolamine pH 9.8) the absorbance of each well at 405 nm was measured with a Titertek Multiskan MC (Flow Laboratories) plate reader interfaced with an IBM PC/AT microcomputer.
Immunoprecipitation of CMVprotein 3A from in vitro translation products. CMV-Q RNA (2 ~g) was translated in a mixture of 50 ~tCi of [3sS]methionine, 1 ~tl of essential amino acid mixture (1 mM each, lacking methionine), 35 vtl of nuclease-treated rabbit reticulocyte lysate (Promega, Madison, Wis., U.S.A.) and sterile distilled water to a total volume of 50 ~tl. After 90 min at 29 °C the translation mixture was 'cleared' by incubation with 25 p.l of a 50~ suspension of Sepharose 2B conjugated with goat anti-mouse immunoglobulin for 15 rain and centrifuged through a 0.2 p.m filter to remove the Sepharose beads. Samples (8 ~tl) of the resulting mixture were incubated with 100 Ixl of hybridoma culture supernatant for 60 min and then for a further 30 to 60 min after the addition of 25 M1 of goat antimouse immunoglobulin-Sepharose (50~ suspension). The beads were washed three times by centrifugation in TST and bound protein was extracted by incubation with SDS-PAGE sample buffer (4~ SDS, l0 mM-Tris-HCl pH 6-8, 10~ 2-mercaptoethanol, 0-4~ bromophenol blue, 20~ glycerol) for 5 rain at 90 °C. Samples (10 Ixl) of total in vitro translation mixture and the specific immunoprecipitates were electrophoresed in a 12 ~ polyacrylamide gel in the buffer system of Laemmli (1970) . The gel was then fixed in 25~ isopropanol : 10% acetic acid (30 min), infiltrated with Enlightening (New England Nuclear) and processed for fluorography.
Ultrastructural labelling of thin sections. Colloidal gold particles of 17 nm diameter were prepared by the reduction of chloroauric acid with sodium citrate and then conjugated to Protein A as described by Roth et al. (1978) .
The leaves of 4-week-old tobacco plants (Nicotiana tabacum cv. Xanthi nc) were inoculated with CMV-Q, and at various times following inoculation tissue samples (2 mm × 2 mm) were fixed with 1 ~ paraformaldehyde, 0.2~ glutaraldehyde in Dulbecco's phosphate-buffered saline containing 1 mM-MgC12 and 1 mM-CaCI2 for 16 to 24 h at 4 °C. Fixed tissue was then stained with 2~ uranyl acetate, dehydrated, and embedded in LR White hydrophilic methacrylate-based resin (Polaron Equipment, Watford, U.K.). Ultrathin serial sections were mounted on Formvar-coated copper grids.
For the labelling of thin sections all incubations were performed by floating grids, section side down, on 20 p.l volumes of the indicated reagent. Non-specific protein binding sites were first quenched by incubation with TST containing 0-5~ BSA for 20 min. Sections were then incubated for 1 h with specific purified MAb diluted to a concentration of 10 p.g/ml in TST containing 0-5"/oo BSA. Excess antibody was removed by extensive rinsing with TST and the sections were then incubated with Protein A-colloidal gold conjugate, diluted to an OD525 of 2-0 in TST, for a further 30 to 60 min. After rinsing, the sections were stained with lead citrate to enhance contrast and viewed with a Philips 300 electron microscope.
RESULTS
Preparation and purification of pXCM3A 13 fusion protein
The pXCM3A 13 expression vector contained an in-frame gene fusion coding for a chimeric protein consisting of the affinity tail of the Protein A gene from Staphylococcus aureus and the entire CMV 3A protein, minus the N-terminal five amino acid residues, under control of the inducible 2 Pr promoter. The theoretical Mr value of this fusion protein was approximately 55000 of which about 34500 was the CMV 3A gene product and the remainder was the truncated Protein A. Since the Protein A portion of the fusion protein lacked the N-terminal signal sequence region, the expressed fusion protein accumulated intracellularly and was released only by cell lysis.
Affinity-purified fusion protein was composed primarily of a single Mr 55000 component when analysed by SDS-PAGE (Fig. 1) . In some instances small amounts of lower M~ species were observed, which may have been due to proteolytic degradation of fusion protein within the cells or during isolation. Typical yields of purified fusion protein ranged from 2 to 5 mg per litre of cells. 
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Ceil fusion and MAb production
The fusion of immune splenocytes from two BALB/c mice, immunized with purified pXCM3A13 fusion protein, with mouse myeloma cells yielded 15 hybridoma cell lines that secreted antibody which bound specifically to the pXCM3A 13 fusion protein and not to Protein A, as tested by ELISA. As a further test, hybridoma culture fluid from each of these cell lines was tested for binding to a second fusion protein, designated pXCN1A17. The pXCN1A17 construct contained part of the gene coding for the viral replicase from cucumber necrosis virus in addition to the truncated Protein A gene and was included in these experiments as an additional control. Only five of the original 15 cell lines produced antibody that bound only to the pXCM3A13 fusion protein and not at all to the pXCN1A17 fusion protein.
ELISA titration data for two particular MAbs showing these different specificities are presented in Fig. 2 . MAb 3H12 bound specifically to immobilized pXCM3A13 fusion protein but did not bind to p X C N 1 A I 7 (Fig. 2b) . In contrast, MAb 1H6 bound strongly to both the pXCM3A13 and pXCN1A17 fusion proteins but did not bind to Protein A alone (Fig. 2a) .
lmmunoprecipitation of in vitro translated 3A protein
As a further test for the specificity of the five MAbs produced against the pXCM3A13 fusion protein they were each tested for their ability to immunoprecipitate the 3A protein produced by in vitro translation. In these experiments all five MAbs behaved essentially identically, and only the data for the 3H12 antibody are presented here.
Translation products of CMV, BMV and tomato aspermy virus (TAV) R N A were separated by S D S -P A G E (12~ polyacrylamide) (Fig. 3 lanes 1, 4 and 6 respectively) . MAb 3H12 specifically immunoprecipitated the Mr 35000 3A protein from CMV RNA translation products ( Fig. 3 lane 2) , whereas control MAb 1H6 did not bind to any of these translated proteins ( Fig. 3 lane 3) . MAb 3H 12 also reacted with the 3A protein translated from TAV RNA (Fig. 3 lane 7) but not with the analogous protein in translation products of BMV RNA (Fig. 3 lane 5).
ImmunogoM labelling o f ultrathin sections
The intracellular distribution of the CMV 3A protein was determined by labelling ultrathin serial sections of virus-infected tobacco tissue with MAb 3H12 followed by Protein Aconjugated colloidal gold.
When sections of interveinal tissue from young upper leaves (approximately 4 to 5 cm in length) systemically infected with CMV (2 weeks post-inoculation) were examined, the most pronounced accumulation of gold was observed over the nucleoli (Fig. 4a, b) . With few exceptions, all of the nucleoli observed in these sections were labelled. Additional specific labelling was observed over the cytoplasm of these cells but there was little labelling of chloroplasts, mitochondria or other cell bodies (Fig. 4c) . In particular, there appeared to be no association of label with the cell wall or with the intercellular space. This pattern of labelling was observed in numerous sections obtained from six separate embeddings and there was no apparent difference between epidermal and mesophyll cells. Thin sections of similar tissue from leaves systemically infected with TAV also showed specific labelling of the nucleoli (Fig. 4e) . The same results were obtained in labelling experiments using three of the other four MAbs to protein 3A; the remaining MAb did not react with aldehyde-fixed material.
Specific labelling of the nucleoli of some mesophyll cells was observed in tissue from a leaf inoculated with CMV only 24 to 30 h previously (Fig. 4d) .
Thin sections of healthy tissue incubated with MAb 3H12 and Protein A-colloidal gold showed a very low level of uniform non-specific labelling with very few, if any, gold particles over nucleoli (Fig. 4f) . As an additional control, thin sections of leaves systemically infected Z N Z M with tobacco ringspot virus were also examined and showed no specific labelling with MAb 3H12 (results not shown). DISCUSSION The construction of cloned chimeric fusion proteins for the preparation of MAbs to nonstructural virus-coded proteins has proved to be a valuable technique. The Protein A-based expression vectors, such as pRIT2T, have advantages over vectors employing a truncated flgalactosidase (lacZ) gene. The Protein A chimeras are generally more soluble than similar lacZ products and the specificity of the Protein A part of the molecule for the Fc region of immunoglobulins can be used to advantage in the single-step affinity purification of these fusion proteins. However, the Protein A region of these fusion proteins is itself extremely immunogenic and good screening assays are needed to distinguish between antibodies specific for the Protein A moiety and the cloned gene of interest. As illustrated by MAb 1H6, it was possible to produce MAbs that bound to the pXCM3A13 fusion protein and not to native Protein A, but which also reacted with another fusion protein, pXCN1A17, containing an entirely different inserted sequence. These results demonstrate that the conformation of Protein A within the fusion protein is sufficiently perturbed so as to expose new antigenic epitopes not accessible on native Protein A. By analogy, it must be realized that the structural conformation of any particular target sequence within a fusion protein may not be identical to that in the native target protein and that this may result in the production of antibodies that recognize the fusion protein but do not bind to the native target protein. This latter possibility was not observed by us, in that all of the MAbs that bound specifically to the pXCM3A13 fusion protein were also able to immunoprecipitate the native 3A protein from in vitro translation mixtures.
The lack of reaction of any of the MAbs to the 3A protein of CMV with the analogous protein from BMV was not surprising considering the relatively limited degree of sequence homology between these proteins. In contrast, the cross-reaction between the 3A protein from TAV and the same protein from CMV with all of these MAbs, by immunoprecipitation, demonstrates that this protein is at least somewhat conserved between these two viruses even though their capsid proteins show only a limited serological relationship.
Recent studies on the location of the p30 protein of TMV and the 3A protein of A1MV have yielded conflicting results which differed according to whether isolated protoplasts or intact tissue were examined. It has been reported that the 3A protein from AIMV is present within a cell wall fraction from virus-infected tobacco tissue (Godefroy-Colburn et al., 1986) and immunogold labelling of thin sections of infected tissue has specifically located this protein within the middle lamella of cell wails (Stussi-Garaud et aL, 1987) . Similarly, the p30 protein of TMV has been shown to be associated with the plasmodesmata of infected cells (Tomenius et al., 1987) . However, studies on the accumulation of these proteins within infected tobacco protoplasts have pointed towards a nuclear involvement. Using a polyclonal antiserum prepared against a C-terminal peptide from the 30K protein, Watanabe et al. (1987) were able to immunoprecipitate specifically the p30 protein of TMV from a nuclear fraction of protoplasts inoculated with TMV, following pulse-labelling with [35S]methionine" Results of similar work on A1MV-infected tobacco protoplasts suggested that the 3A protein was associated with a 1000 g subcellular fraction containing primarily nuclei, chloroplasts and membranes attached to these organelles (Van Pelt-Heerschap et al., 1987) .
Using a MAb prepared to the 3A protein of CMV we have located this protein within the nucleoli of cells recently infected with virus (24 to 30 h post-inoculation) as well as cells from systemically infected leaf tissue. Different amounts of 3A protein were also observed in the Fig. 4 . Immunogold labelling of 3A protein in infected tobacco tissue. Immunogold labelling with MAb 3H 12 of ultrathin sections of systemically infected tissue revealed an accumulation of gold marker over the nucleoli of these cells (a, b) . While some labelling within the cytoplasm was observed, very little marker was found associated with chloroplasts or cell walls (c). 3A protein could also be detected within the nucleoli of cells of inoculated tissue 24 to 30 h following inoculation (d) and ceils systemically infected with TAV could also be specifically labelled with MAb 3H12 (e). Thin sections obtained from healthy tissue showed little if any labelling with MAb 3H12 (f). Bar markers represent 0.5 Ixm.
cytoplasm of infected cells, but very little, or none, was present in chloroplasts or mitochondria or in association with the cell wall. While these results indicate that the nucleolus is a site of accumulation of the 3A protein, the function of this protein remains a matter of speculation; however, one possible role would be as a regulator of host gene transcription. It has been postulated by Atabekov & Dorokhov (1984) that one possible function of a virus-encoded transport protein would be to repress a host resistance response, presumably caused by virus infection, that results in the shut-off of intercellular communication. The inhibition of such a host response might allow the free spread of the infectious viral agent.
Many questions remain to be answered regarding the exact biochemical function of the 3A proteins from the tripartite genome viruses CMV, A1MV and BMV, and what role, if any, these proteins play in the undoubtedly complex process of virus transport.
